Prognostic Value of Transvalvular Flow Rate in Aortic Stenosis: Implications for Risk Stratification.

Background: Timing of treatment of aortic stenosis (AS) is of key importance. AS severity is currently determined by transthoracic echocardiography (TTE) with a main focus on mean trans‐aortic gradients. However, echocardiography has its limitations. The transvalvular flow rate (Q), is defined as th...

Descripción completa

Detalles Bibliográficos
Publicado en:Echocardiography Vol. 42; no. 1; pp. 1 - 11
Autores principales: Bar Gil, Elad M., Sergienko, Ruslan, Roguin, Nir, Birman, Shoham, Kobal, Sergio L.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Jan2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183918223&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 183918223
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07422822
        GSE
      jtl: Echocardiography
      issn: 07422822
      maglogo: Y
    pubinfo:
      dt: Jan2025
      vid: 42
      iid: 1
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        183918223
        183918223
        183918223
        10.1111/echo.70077
        183918223
      ppf: 1
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Prognostic Value of Transvalvular Flow Rate in Aortic Stenosis: Implications for Risk Stratification.
      aug:
        au:
          Bar Gil, Elad M.
          Sergienko, Ruslan
          Roguin, Nir
          Birman, Shoham
          Kobal, Sergio L.
        affil: Joyce and Irving Goldman Medical School, Faculty of Health Sciences, Ben‐Gurion University of the Negev, Beer‐Sheba, Israel
      sug:
        subj:
          Aortic Valve Stenosis
          Echocardiography Methods
          Stroke Volume Physiology
          Severity of Illness Evaluation
          Risk Assessment
          Human
          Male
          Female
          Aged
          Aged, 80 and Over
          Retrospective Design
          Record Review
          Aortic Valve Stenosis Radiography
          Aortic Valve Stenosis Diagnosis
          Aortic Valve Stenosis Prognosis
          Aortic Valve Stenosis Surgery
          Aortic Valve Stenosis Classification
          Aortic Valve Stenosis Risk Factors
          Aortic Valve Stenosis Mortality
          Mortality Risk Factors
          Heart Failure Prevention and Control
          Transcatheter Aortic Valve Implantation Methods
          Heart Valve Prosthesis Methods
          Univariate Statistics
          Multivariate Analysis
          Multiple Regression
          Kaplan-Meier Estimator
          Variable
          Survival Analysis
          Statistical Significance
          Data Analysis Software
          Descriptive Statistics
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Background: Timing of treatment of aortic stenosis (AS) is of key importance. AS severity is currently determined by transthoracic echocardiography (TTE) with a main focus on mean trans‐aortic gradients. However, echocardiography has its limitations. The transvalvular flow rate (Q), is defined as the ratio of stroke volume (SV) to ejection time (ET): Q = SV/ET. Purpose: To examine the prognostic value of aortic transvalvular flow rate (Q), in patients with moderate or severe AS. Methods: Clinical data from 824 patients diagnosed with AS between 2017 and 2020, and followed up until 2022 for four clinical outcomes: mortality, congestive heart failure (CHF), transcatheter aortic valve implantation (TAVI), and surgical aortic valve replacement (SAVR) was used for this retrospective study. Univariate and multivariate regression analyses were performed for the whole cohort and for the moderate AS subgroup, to identify prognostic markers. Kaplan‐Meier survival analysis was conducted for different transvalvular flow rates and AS severities. Results: Findings demonstrate that lower Q is a significant risk factor for all‐cause mortality even when adjusted for other echocardiographic and clinical variables. Survival analysis for the composite outcome occurrence (TAVI, SAVR, CHF, or mortality) and mortality showed significant differences between groups stratified by AS severity and Q (p value <0.0001). Specifically, Q was more substantial in the moderate AS group. Conclusion: Transvalvular flow rate (Q) is independently prognostic for all‐cause mortality. Furthermore, patients with moderate AS and lower Q should be closely monitored. Flow rate assessment should be integrated into the diagnosis, classification, and prognosis framework for AS.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N